Orbimed Advisors Trims $125 After Breakout Year in Biotech
A major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Discover what economic indices reveal about the economy and markets. This intro explains how to read signals and translate them into actions.
8,841 articlesA major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
A major stake sale in Albertsons by a large hedge fund sparks questions about what insiders know and how it affects t...
AAPD’s 3.43% yield looks appealing, but the bear-on-Apple fund relies on collateral interest instead of dividends. A ...
Investors want to know if now is the time figma stock? This guide breaks down how to evaluate Figma stock, what metri...
IonQ posted quarterly results that beat expectations, triggering a notable after-hours rally. Analysts warn the stock...
TG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
Retirement planning can feel overwhelming, and a tempting, seemingly simple move can backfire. Here’s how to spot hid...
A fintech just reported a blowout quarter, yet the stock still looks cheap to patient investors. This analysis breaks...
A gold miner’s stock has doubled in 12 months and just raised its dividend by 60%. This deep-dive explains what drive...
A sharp February move put Remitly Global in the spotlight. This article breaks down the catalysts behind the rally, t...
Online rumors can move faster than stock quotes and drain your wallet. Learn how queen latifah just reminded us to pa...
Joby Aviation has faced a rough start to 2026 after a big rally in 2025. This guide explains whether the stock is rig...